{"id":"https://openalex.org/W7225619386","doi":"https://doi.org/10.21203/rs.3.rs-11243327/v1","title":"Real-World Outcomes of the Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: The SANTEE Study","display_name":"Real-World Outcomes of the Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: The SANTEE Study","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225619386","doi":"https://doi.org/10.21203/rs.3.rs-11243327/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11243327/v1","doi":"https://doi.org/10.21203/rs.3.rs-11243327/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11243327/v1","pdf_url":"https://www.researchsquare.com/article/rs-11243327/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11243327/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007762846","display_name":"Adam E. Pflugrath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Pflugrath","raw_affiliation_strings":["Jervey Eye Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jervey Eye Group","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5092793928","display_name":"Joanna Mendez-Silva","orcid":"https://orcid.org/0000-0002-0639-3787","observed_orcids":["https://orcid.org/0000-0002-0639-3787"]},"institutions":[{"id":"https://openalex.org/I155781252","display_name":"University of South Carolina","ror":"https://ror.org/02b6qw903","country_code":"US","type":"education","lineage":["https://openalex.org/I155781252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanna Mendez-Silva","raw_affiliation_strings":["University of South Carolina School of Medicine Greenville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of South Carolina School of Medicine Greenville","institution_ids":["https://openalex.org/I155781252"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9480000138282776},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":1.0},{"id":"https://openalex.org/keywords/faricimab","display_name":"faricimab","score":0.8460000157356262},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/implant-safety","display_name":"implant safety","score":0.5440000295639038},{"id":"https://openalex.org/keywords/endophthalmitis","display_name":"endophthalmitis","score":0.8500000238418579},{"id":"https://openalex.org/keywords/vitreous-hemorrhage","display_name":"vitreous hemorrhage","score":0.9599999785423279},{"id":"https://openalex.org/keywords/visual-acuity-outcomes","display_name":"visual acuity outcomes","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9483000040054321},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.8924999833106995},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.8374000191688538},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6728000044822693},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6693999767303467},{"id":"https://openalex.org/C2777235844","wikidata":"https://www.wikidata.org/wiki/Q1294912","display_name":"Endophthalmitis","level":2,"score":0.5612000226974487},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.5350000262260437},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5105000138282776},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5060999989509583},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.43130001425743103},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.3959999978542328},{"id":"https://openalex.org/C2776148792","wikidata":"https://www.wikidata.org/wiki/Q3041498","display_name":"Eye disease","level":2,"score":0.37130001187324524},{"id":"https://openalex.org/C32802771","wikidata":"https://www.wikidata.org/wiki/Q2443617","display_name":"Port (circuit theory)","level":2,"score":0.3617999851703644},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.3370000123977661},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.3082999885082245},{"id":"https://openalex.org/C2781411149","wikidata":"https://www.wikidata.org/wiki/Q486975","display_name":"Implant","level":2,"score":0.3066999912261963},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.28839999437332153},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2750000059604645},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.2745000123977661},{"id":"https://openalex.org/C2777104736","wikidata":"https://www.wikidata.org/wiki/Q1529650","display_name":"Vitreous hemorrhage","level":4,"score":0.26969999074935913},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.25200000405311584}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11243327/v1","doi":"https://doi.org/10.21203/rs.3.rs-11243327/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11243327/v1","pdf_url":"https://www.researchsquare.com/article/rs-11243327/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11243327/v1","doi":"https://doi.org/10.21203/rs.3.rs-11243327/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11243327/v1","pdf_url":"https://www.researchsquare.com/article/rs-11243327/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225619386.pdf","grobid_xml":"https://content.openalex.org/works/W7225619386.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W2017194458","https://openalex.org/W2753708825","https://openalex.org/W2777721386","https://openalex.org/W3119176982","https://openalex.org/W3146812839","https://openalex.org/W3202179277","https://openalex.org/W4280575202","https://openalex.org/W4280580763","https://openalex.org/W4322766185","https://openalex.org/W4392545215","https://openalex.org/W4399913470","https://openalex.org/W4401630201","https://openalex.org/W4402031776","https://openalex.org/W4405925709","https://openalex.org/W4408186618","https://openalex.org/W4410221483","https://openalex.org/W4413915614","https://openalex.org/W7161641183","https://openalex.org/W7212055279","https://openalex.org/W7214117767"],"related_works":["https://openalex.org/W2933377962","https://openalex.org/W7214117767","https://openalex.org/W4391740967","https://openalex.org/W7165025841","https://openalex.org/W4402031776","https://openalex.org/W4392096912","https://openalex.org/W4389384188","https://openalex.org/W4297266347","https://openalex.org/W4210906080","https://openalex.org/W3103660393"],"abstract_inverted_index":{"Abstract":[0],"Purpose.":[1],"To":[2],"report":[3],"real-world":[4],"safety":[5,61],"and":[6,88,163,177,220,236],"treatment-procedure":[7],"frequency":[8],"with":[9,18,33,133,207,214,229],"the":[10,64,77,98,174,233],"ranibizumab":[11],"port":[12],"delivery":[13],"system":[14],"(PDS)":[15],"in":[16,129,143,225],"eyes":[17,43,58,66,131],"neovascular":[19],"age-related":[20],"macular":[21,26],"degeneration":[22],"(nAMD)":[23],"or":[24,116],"diabetic":[25],"edema":[27],"(DME),":[28],"most":[29],"of":[30,41,187],"which":[31],"managed":[32,206],"faricimab.":[34],"Methods.":[35],"Retrospective,":[36],"consecutive,":[37],"single-center":[38],"case":[39],"series":[40],"81":[42],"(64":[44],"patients)":[45],"implanted":[46],"October":[47],"2024":[48],"to":[49,53,60,72,158,165],"March":[50],"2026,":[51],"followed":[52,67],"28":[54],"September":[55],"2026.":[56],"All":[57],"contributed":[59,71],"(92.5":[62],"implant-years);":[63],"79":[65,82],"\u2265":[68],"3":[69,144],"months":[70],"effectiveness,":[73],"assessed":[74],"principally":[75],"through":[76,173,232],"second":[78,175,234],"refill-exchange.":[79],"Results.":[80],"Of":[81],"effectiveness":[83],"eyes,":[84,190],"61":[85],"had":[86],"nAMD":[87,145,161,189],"18":[89],"DME;":[90],"74":[91],"(93.7%)":[92],"were":[93,141],"on":[94],"faricimab":[95,208],"before":[96,209],"implantation;":[97],"mean":[99],"preimplant":[100],"interval":[101,149,219],"was":[102,109,150,171,180,192,212],"7.2":[103],"weeks.":[104],"Over":[105],"92.5":[106,240],"implant-years":[107],"there":[108],"no":[110,237],"endophthalmitis,":[111],"conjunctival":[112],"erosion,":[113],"implant":[114],"dislocation,":[115],"explantation":[117],"(upper":[118],"95%":[119],"confidence":[120],"limit":[121],"3.99":[122],"per":[123,160,167],"100":[124],"implant-years).":[125],"Vitreous":[126],"hemorrhage":[127],"occurred":[128],"4":[130],"(3":[132],"DME),":[134],"2":[135],"requiring":[136],"vitrectomy.":[137],"Four":[138],"supplemental":[139],"injections":[140],"given":[142],"eyes.":[146],"Median":[147],"refill":[148,218],"25":[151],"weeks;":[152],"treatment":[153,227],"procedures":[154],"fell":[155],"from":[156],"5.98":[157],"2.06":[159],"eye":[162],"5.72":[164],"2.00":[166],"DME":[168],"eye.":[169,200],"Acuity":[170],"unchanged":[172],"refill-exchange":[176,235],"anatomic":[178],"control":[179],"maintained.":[181],"In":[182,202],"an":[183,221],"exploratory":[184],"third-refill":[185],"analysis":[186],"22":[188],"acuity":[191,230],"0.088":[193],"logMAR":[194],"worse,":[195],"substantially":[196],"influenced":[197],"by":[198],"one":[199],"Conclusion.":[201],"a":[203,215],"cohort":[204],"predominantly":[205],"implantation,":[210],"PDS":[211],"associated":[213],"25-week":[216],"median":[217],"approximately":[222],"two-thirds":[223],"reduction":[224],"anti-VEGF":[226],"procedures,":[228],"maintained":[231],"endophthalmitis":[238],"over":[239],"implant-years.":[241]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}